<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Dr. Dagna Constenla - Health Economist and Public Health Expert</title>
    <style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f4f4f4;
            color: #333;
        }
        header {
            background-color: #4CAF50;
            color: white;
            text-align: center;
            padding: 1em 0;
        }
        .container {
            width: 80%;
            margin: auto;
            overflow: hidden;
        }
        section {
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            box-shadow: 0 0 10px rgba(0,0,0,0.1);
        }
        h1, h2 {
            color: #333;
        }
        footer {
            background-color: #4CAF50;
            color: white;
            text-align: center;
            padding: 1em 0;
            position: fixed;
            width: 100%;
            bottom: 0;
        }
    </style>
</head>
<body>
    <header>
        <h1>Dr. Dagna Constenla</h1>
        <p>Health Economist and Public Health Expert</p>
    </header>

    <div class="container">
        <section id="about-me">
            <h2>About Me</h2>
            <p>
                I am a self-directed and driven pharmaceutical professional with comprehensive accomplishments leading medical value strategy, pipeline asset optimization, market research, demand forecasting, and cross-functional teams to achieve goals. An innovative thinker with strong biotechnology, vaccine research, chemical engineering, and business acumen. Demonstrated success in informing quality, impactful asset development strategies, including health economic models, clinical development protocols, and real-world evidence plans to meet the needs of payers, patients, policymakers, and physicians. Recognized for implementing novel forecast approaches to enhance consistency, efficiency, and add significant insights into future market direction. Expertise includes developing vaccines, pharmaceuticals, and medical devices; conducting value evidence generation and early asset vaccine valuation; matrix leadership and managing people; advising leaders of pharmaceutical companies; and communicating business propositions in high-pressure settings to royalty, venture capitalists, pharmaceutical leaders, and media.
            </p>
        </section>

        <section id="projects">
            <h2>Projects</h2>
            <p>Details about notable projects and achievements will go here.</p>
        </section>

        <section id="skills">
            <h2>Skills</h2>
            <ul>
                <li>Medical Value Strategy</li>
                <li>Pipeline Asset Optimization</li>
                <li>Market Research</li>
                <li>Demand Forecasting</li>
                <li>Biotechnology</li>
                <li>Vaccine Research</li>
                <li>Chemical Engineering</li>
                <li>Health Economic Models</li>
                <li>Clinical Development Protocols</li>
                <li>Real-World Evidence Plans</li>
                <li>Matrix Leadership</li>
                <li>Communicating Business Propositions</li>
            </ul>
        </section>

        <section id="contact">
            <h2>Contact Information</h2>
            <p>Email: [Your Email]</p>
            <p>LinkedIn: [Your LinkedIn Profile]</p>
        </section>
    </div>

    <footer>
        <p>&copy; 2024 Dr. Dagna Constenla. All rights reserved.</p>
    </footer>
</body>
</html>